Physician profile
Craig Mines
NPI 1609874726
$38,742.48
in general payments reported to CMS, 2019-2025
27 companies · $413 in 2025
The $413 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,312 · 2020: $6,336 · 2021: $97.75 · 2022: $1,633 · 2023: $22K · 2024: $3,068 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $7,067 · Food and Beverage: $1,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,400.00 |
| Travel and Lodging | $7,067.27 |
| Food and Beverage | $1,896.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Think Surgical, INC. | $21,648.91 | 2023 | |
| Lilly USA, LLC | $8,947.12 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $2,928.13 | 2024 | Persona |
| Conformis, INC. | $1,678.55 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $1,573.16 | 2022-2023 | Seglentis |
| Biofire Diagnostics, LLC | $425.00 | 2020 | |
| Zyla Life Sciences, INC. | $248.38 | 2019-2020 | |
| Radius Health, INC. | $226.51 | 2019-2025 | Tymlos |
| Vertex Pharmaceuticals Incorporated | $199.70 | 2024-2025 | |
| Horizon Therapeutics Plc | $179.60 | 2019-2023 | Krystexxa |
| Depuy Synthes Sales INC. | $93.66 | 2021-2023 | Motoband |
| Pfizer INC. | $77.83 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $63.81 | 2020-2025 | Zilretta |
| Sonex Health, INC. | $60.47 | 2023 | Sx-One Microknife |
| Becton, Dickinson and Company | $60.00 | 2025 | Arista |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $53.34 | 2021-2022 | |
| Fidia Pharma USA INC. | $41.61 | 2019-2025 | Triluron, Hymovis |
| Davol INC. | $41.32 | 2022-2025 | Arista |
| Ermi LLC | $33.13 | 2019-2024 | |
| Amgen INC. | $32.74 | 2024-2025 | Evenity, Prolia, Krystexxa |
| Axogen | $27.34 | 2025 | |
| Baxter Healthcare | $23.44 | 2023 | Tisseel |
| Bioventus LLC | $20.23 | 2019 | |
| Acumed LLC | $16.00 | 2019 | |
| Tenex Health INC. | $14.82 | 2021 | |
| Access Pro Medical, LLC | $14.01 | 2025 | Matriderm |
| Pacira Therapeutics, INC. | $13.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Mines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.